Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/31515
Full metadata record
DC FieldValue
dc.contributor.authorZanchin, Túlio Neutzling
dc.contributor.authorSerafini, Cássio Battisti
dc.contributor.authorBrandão, Francine Silva
dc.contributor.authorNery, José Augusto da Costa
dc.date.accessioned2019-02-10T17:26:25Z
dc.date.available2019-02-10T17:26:25Z
dc.date.issued2018
dc.identifier.citationZANCHIN, Túlio Neutzling; et al. Polyhexanide 0.2% in treatment of trophic foot ulcers in leprosy - preliminary study. An Bras Dermatol., v.93, n.1, p.145-147, 2018.
dc.identifier.issn0365-0596
dc.identifier.urihttps://www.arca.fiocruz.br/handle/icict/31515
dc.language.isoeng
dc.publisherSociedade Brasileira de Dermatologia
dc.rightsopen access
dc.subject.otherHanseníase
dc.subject.otherÚlcera do pé
dc.subject.otherResultado do tratamento
dc.titlePolyhexanide 0.2% in treatment of trophic foot ulcers in leprosy - preliminary study
dc.typeArticle
dc.identifier.doi10.1590/abd1806-4841.20186655
dc.description.abstractenLeprosy is a chronic infectious disease caused by Mycobacterium leprae, which affects peripheral nerves, skin and mucous membranes. The impairment of neural function as well as sensory or sensory-motor disabilities in leprosy continue to be a problem that requires careful attention in the management of patients with the aim to avoid or minimize their progression to prevent sequelae. One of the most common characteristics of these ulcers is the tendency to chronicity, with variable therapeutic response. In this article, we shall discuss the therapeutic management of thirteen trophic leprosy ulcers in eight patients using polyhexanide 0.2% products.
dc.creator.affilliationSanta Casa da Misericórida do Rio de Janeiro. Departamento de Dermatologia. Instituto de Dermatologia Prof. Rubem David Azulay. Rio de Janeiroi, RJ, Brasil.
dc.creator.affilliationHospital Central do Exército. Departamento de Dermatologia Tropical. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationSanta Casa da Misericórida do Rio de Janeiro. Instituto de Dermatologia Prof. Rubem David Azulay. Departamento de Dermatologia Sanitária. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationSanta Casa da Misericórida do Rio de Janeiro. Instituto de Dermatologia Prof. Rubem David Azulay. Departamento de Dermatologia Sanitária. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Ambulatório Souza Araújo. Rio de Janeiro, RJ, Brasil.
dc.subject.enLeprosy
dc.subject.enTreatment outcome
dc.subject.enFoot ulcer
Appears in Collections:IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
joseaugustoc_nery_etal_IOC_2018.pdf351.7 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.